ANNUAL REPORT 2021

LUNDBECK ANNUAL REPORT 2021 = CONTENTS 15/111 We will continue to infuse the organization with more flexible and agile ways of working both in terms of how we work and the way we work, simplifying our processes and accelerating our ability to test and learn for faster, higher-quality decision making. By leveraging digital technologies and capabilities where it can make us faster and more effective, we can make the best use of our talent and competencies across functions that will enable the development of best or first-in-class products and get them to patients faster. Just as much as we need a global and cross functional working organization, we need a diverse and inclusive one too. We aim to enrich our decision making through diversity of thought across all that we do. Diversity comes from having inclusive teams made up of people with different perspectives and experiences - and that comes from having an organization of people with different nationalities, race, gender and sexual orientation. We have a zero-tolerance approach to harassment, racism and discrimination of any kind and clear processes for employees and stakeholders to voice their concerns and have them addressed. Equally important, we will continue to ensure sustainable business practices following leading environmental, social and corporate governance criteria. Our ability to successfully deliver on our strategy takes the entire Lundbeck team collaborating around our shared purpose of restoring brain health, so every person can be their best. OUR LONG-TERM AMBITION Over the past two years, we have made strategic choices around where we put our efforts across our entire business. With the choices we made, we have lofty ambitions for what the future should look like when we succeed. Our ambition is to be #1 in Brain Health in the eyes of the patients we tirelessly serve - so what does that mean? WHAT DOES IT MEAN TO BE #1 IN BRAIN HEALTH? We aim to be the leader in brain health, in the eyes of our patients. We know we are well on our way when: We have top quartile financial results in our peer group. By focusing on our patients and our products, top financial performance will follow. We have a premier neuroscience pipeline filled with assets that will make a difference to our patients. We have an established and focused commercial footprint around commercially attractive patient segments in niche and rare neurology and psychiatry. We are best in class in terms of how we use digital technologies to improve patient outcomes. We are a company leveraging diversity, where top talents within neuroscience aspire to work We continue to deliver sustainable growth in revenue and profitability. And finally, we are on track to be carbon neutral before 2050. Giving back to society is equally as important as financial performance. The culmination of all this together is what will make us #1 in Brain Health, serving the people who need new medicines to help them conquer brain diseases. It will take every brain being fully "in the game" to achieve it. We continue to prioritize and act, year by year to stay on track.

View entire presentation